Prosecution Insights
Last updated: May 29, 2026

Examiner: WEHRHEIM, LINDSEY GAIL

Tech Center 3700 • Art Units: 3762 3792 3799

This examiner grants 79% of resolved cases

Performance Statistics

78.6%
Allow Rate
+8.6% vs TC avg
583
Total Applications
+20.5%
Interview Lift
1241
Avg Prosecution Days
Based on 557 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
14.1%
§102 Novelty
74.6%
§103 Obviousness
3.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19241022 IMPLANTABLE MEDICAL DEVICES AND RELATED METHODS THEREOF Final Rejection Puzzle Medical Devices Inc.
18239696 GUIDEWIRE POSITIONING DEVICES AND SYSTEMS Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18364081 BALLISTOCARDIOGRAM SENSOR Non-Final OA Electronics and Telecommunications Research Institute
18118537 CIRCULATORY SUPPORT DEVICE WITH STEERABLE CANNULA Final Rejection Boston Scientific Scimed Inc.
18223393 BED SYSTEM WITH FEATURES TO TRACK CHANGES IN BODY WEIGHT WITHIN A SLEEP SESSION Non-Final OA Sleep Number Corporation
18546070 CATHETER BLOOD PUMPS WITH COLLAPSIBLE PUMP HOUSING AND SENSOR SYSTEM Non-Final OA Shifamed Holdings, LLC
18223984 SYSTEMS AND METHODS FOR CLOSED-LOOP DETERMINATION OF STIMULATION PARAMETER SETTINGS FOR AN ELECTRICAL SIMULATION SYSTEM Non-Final OA Boston Scientific Neuromodulation Corporation
18458432 WEARABLE CARDIAC DEFIBRILLATOR SYSTEM AUTHENTICATING PERSON ACTUATING CANCEL SWITCH Non-Final OA West Affum Holdings DAC
18453008 DRIVELINE SYSTEM AND METHOD FOR AN IMPLANTABLE MEDICAL DEVICE Non-Final OA CH Biomedical, Inc.
18231174 METHOD AND APPARATUS FOR NEUROENHANCEMENT TO FACILITATE LEARNING AND PERFORMANCE Non-Final OA Neuroenhancement Lab, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month